• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿败血症的分布、抗菌药物耐药性及死亡预测因素

Distribution, antimicrobial resistance and predictors of mortality in neonatal sepsis.

作者信息

Bandyopadhyay T, Kumar A, Saili A, Randhawa V S

机构信息

Department of Neonatology, Lady Hardinge Medical College, New Delhi, India.

Department of Microbiology, Lady Hardinge Medical College, New Delhi, India.

出版信息

J Neonatal Perinatal Med. 2018;11(2):145-153. doi: 10.3233/NPM-1765.

DOI:10.3233/NPM-1765
PMID:29991144
Abstract

OBJECTIVE

The aim of this study is to investigate etiological agents, patterns of antimicrobial resistance and predictors of mortality in culture proven neonatal sepsis.

METHOD

This is a twenty-four month retrospective cohort study of infants with culture proven sepsis. Demographic data, type of isolates and its sensitivity pattern were recorded. Multidrug resistant gram-negative isolates were defined as resistance to any three of five antibiotic classes: extended-spectrum cephalosporins, carbapenems, aminoglycosides, fluoroquinolones and piperacillin-tazobactam.

RESULT

A total of 183 case with culture positive sepsis were identified. Early onset sepsis occurred in 59% of cases. The majority of isolates (56.2%) were gram-positive but the most common individual isolates were klebsiella spp. (31.1%), Staphylococcus aureus (24.5%) and coagulase-negative staphylococci (CONS) (22.9%). The pathogen mix in early-onset did not differ from late-onset sepsis. High rates of multidrug resistance were observed in klebsiella spp. (49.1%), Escherichia coli (50%), citrobacter spp (50%), acinetobacter spp. (28.5%), pseudomonas spp. (100%) isolates. Methicillin resistance prevailed in 16.6% of coagulase-negative staphylococci, 24.4% of Staphylococcus aureus and 62.5% of enterococcus spp. Multivariate analysis revealed invasive ventilation and early onset sepsis to be independently associated with increased risk of mortality in contrast to breast milk feeding which is associated with decreased risk of mortality.

CONCLUSION

A high degree of antimicrobial resistance underscores the need to understand the pathogenesis of resistance, curtail the irrational prescription of antibiotics in neonates and the requirement for measures to prevent it in low-income and middle-income countries.

摘要

目的

本研究旨在调查经培养证实的新生儿败血症的病原体、抗菌药物耐药模式及死亡预测因素。

方法

这是一项对经培养证实患有败血症的婴儿进行的为期24个月的回顾性队列研究。记录人口统计学数据、分离株类型及其敏感性模式。耐多药革兰氏阴性分离株定义为对以下五类抗生素中的任意三种耐药:广谱头孢菌素、碳青霉烯类、氨基糖苷类、氟喹诺酮类和哌拉西林-他唑巴坦。

结果

共识别出183例血培养阳性的败血症病例。59%的病例发生早发型败血症。大多数分离株(56.2%)为革兰氏阳性,但最常见的单一分离株是克雷伯菌属(31.1%)、金黄色葡萄球菌(24.5%)和凝固酶阴性葡萄球菌(CONS)(22.9%)。早发型和晚发型败血症的病原体组合无差异。在克雷伯菌属(49.1%)、大肠杆菌(50%)、柠檬酸杆菌属(50%)、不动杆菌属(28.5%)、假单胞菌属(100%)分离株中观察到高耐多药率。16.6%的凝固酶阴性葡萄球菌、24.4%的金黄色葡萄球菌和62.5%的肠球菌属存在耐甲氧西林情况。多变量分析显示,有创通气和早发型败血症与死亡风险增加独立相关,而母乳喂养则与死亡风险降低相关。

结论

高度的抗菌药物耐药性凸显了了解耐药机制、减少新生儿抗生素不合理处方的必要性,以及在低收入和中等收入国家采取预防措施的需求。

相似文献

1
Distribution, antimicrobial resistance and predictors of mortality in neonatal sepsis.新生儿败血症的分布、抗菌药物耐药性及死亡预测因素
J Neonatal Perinatal Med. 2018;11(2):145-153. doi: 10.3233/NPM-1765.
2
Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study.印度德里三级保健中心出生的新生儿败血症病原体的特征和抗菌药物耐药性:一项队列研究。
Lancet Glob Health. 2016 Oct;4(10):e752-60. doi: 10.1016/S2214-109X(16)30148-6.
3
Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis.新生儿败血症中细菌病原体的分布特征及耐药性的文献综述。
J Matern Fetal Neonatal Med. 2022 Mar;35(5):861-870. doi: 10.1080/14767058.2020.1732342. Epub 2020 Feb 26.
4
Bacteriological profile and antibiotic susceptibility of neonatal sepsis in neonatal intensive care unit of a tertiary hospital in Nepal.尼泊尔一家三级医院新生儿重症监护病房新生儿败血症的细菌学特征及抗生素敏感性
BMC Pediatr. 2018 Jun 27;18(1):208. doi: 10.1186/s12887-018-1176-x.
5
[Comparative analysis of the pathogens responsible for hospital acquired and community acquired late onset neonatal septicemia].医院获得性与社区获得性迟发型新生儿败血症病原菌的比较分析
Zhonghua Er Ke Za Zhi. 2008 Feb;46(2):124-7.
6
Epidemiology, microbiological profile, and outcome of culture positive sepsis among outborn neonates at a tertiary hospital in Northern India.印度北部一家三级医院出生后新生儿阳性培养败血症的流行病学、微生物学特征和结局。
J Matern Fetal Neonatal Med. 2022 Dec;35(25):7948-7956. doi: 10.1080/14767058.2021.1939300. Epub 2021 Jun 27.
7
Etiology, Antibiotic Resistance and Risk Factors for Neonatal Sepsis in a Large Referral Center in Zambia.赞比亚一家大型转诊中心新生儿败血症的病因、抗生素耐药性及风险因素
Pediatr Infect Dis J. 2016 Jul;35(7):e191-8. doi: 10.1097/INF.0000000000001154.
8
Etiology of early onset neonatal sepsis in neonatal intensive care unit - Mansoura, Egypt.埃及曼苏拉新生儿重症监护病房早发型新生儿败血症的病因
J Neonatal Perinatal Med. 2018;11(3):323-330. doi: 10.3233/NPM-17128.
9
Pathogen and antimicrobial resistance profiles of culture-proven neonatal sepsis in Southwest China, 1990-2014.1990 - 2014年中国西南部经培养证实的新生儿败血症的病原体及抗菌药物耐药性概况
J Paediatr Child Health. 2016 Oct;52(10):939-943. doi: 10.1111/jpc.13278. Epub 2016 Aug 8.
10
Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS).抗生素耐药性、药物靶点达成率、细菌致病性和毒力,以及抗生素的可及性和可负担性对新生儿败血症结局的影响:一项国际微生物学和药物评价前瞻性子研究(BARNARDS)。
Lancet Infect Dis. 2021 Dec;21(12):1677-1688. doi: 10.1016/S1473-3099(21)00050-5. Epub 2021 Aug 9.

引用本文的文献

1
Breastfeeding Patterns, Chemical Pathology, and Antibiotic Resistance in Lactating Mothers: A Spatial Analysis of Nutritional, Toxicological, and Antimicrobial Implications.哺乳期母亲的母乳喂养模式、化学病理学与抗生素耐药性:营养、毒理学及抗菌意义的空间分析
Cureus. 2025 Jul 7;17(7):e87469. doi: 10.7759/cureus.87469. eCollection 2025 Jul.
2
Characteristics of Neonates with Sepsis Associated with Antimicrobial Resistance and Mortality in a Tertiary Hospital in Mexico: A Retrospective Observational Study.墨西哥一家三级医院中与抗菌药物耐药性及死亡率相关的脓毒症新生儿的特征:一项回顾性观察研究
Pathogens. 2025 Jun 14;14(6):588. doi: 10.3390/pathogens14060588.
3
Antibiotic strategies for neonatal sepsis: navigating efficacy and emerging resistance patterns.
新生儿败血症的抗生素治疗策略:应对疗效与新出现的耐药模式
Eur J Pediatr. 2025 Jun 24;184(7):439. doi: 10.1007/s00431-025-06271-w.
4
Severe Neonatal Morbidity and All-Cause and Cause-Specific Mortality Through Infancy and Late Adolescence.严重新生儿发病率以及直至婴儿期和青春晚期的全因死亡率和特定病因死亡率。
JAMA Pediatr. 2025 Jun 10. doi: 10.1001/jamapediatrics.2025.1873.
5
Bacteria and host: what does this mean for sepsis bottleneck?细菌与宿主:这对脓毒症瓶颈意味着什么?
World J Emerg Med. 2025;16(1):10-17. doi: 10.5847/wjem.j.1920-8642.2025.001.
6
Molecular and clinical insights into extended-spectrum β-lactamase genes of Klebsiella pneumoniae isolated from neonatal sepsis in Ethiopia.从埃塞俄比亚新生儿败血症中分离出的肺炎克雷伯菌超广谱β-内酰胺酶基因的分子与临床见解
BMC Infect Dis. 2024 Dec 18;24(1):1442. doi: 10.1186/s12879-024-10344-w.
7
Beyond Early- and Late-onset Neonatal Sepsis Definitions: What are the Current Causes of Neonatal Sepsis Globally? A Systematic Review and Meta-analysis of the Evidence.超越早发型和晚发型新生儿败血症的定义:全球新生儿败血症的当前病因有哪些?一项证据的系统评价和荟萃分析
Pediatr Infect Dis J. 2024 Sep 12;43(12):1182-90. doi: 10.1097/INF.0000000000004485.
8
Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries.评估三种抗生素联合方案治疗中低收入国家新生儿败血症的革兰氏阴性菌。
Nat Commun. 2024 May 10;15(1):3947. doi: 10.1038/s41467-024-48296-z.
9
Time to Death and Its Predictors among Neonates Hospitalized with Sepsis in Eastern Ethiopia.东非因败血症住院新生儿的死亡时间及其预测因素。
Biomed Res Int. 2024 Apr 5;2024:2594271. doi: 10.1155/2024/2594271. eCollection 2024.
10
Reintroduction of Legacy Antibiotics in Neonatal Sepsis: The Special Role of Fosfomycin and Colistin.传统抗生素在新生儿败血症中的重新应用:磷霉素和黏菌素的特殊作用
Antibiotics (Basel). 2024 Apr 5;13(4):333. doi: 10.3390/antibiotics13040333.